The Journal of Heart and Lung Transplantation
Volume 25, Issue 5 , Pages 504-509 , May 2006

Improved Survival After Acute Myocardial Infarction Complicated by Cardiogenic Shock With Circulatory Support and Transplantation: Comparing Aggressive Intervention With Conservative Treatment

  • Wakkas Tayara, MD

      Affiliations

    • Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
  • ,
  • Randall C. Starling, MD, MPH

      Affiliations

    • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
  • ,
  • Mohamad H. Yamani, MD

      Affiliations

    • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • Corresponding Author InformationReprint requests: Mohamad H. Yamani, MD, Department of Cardiology, Cleveland Clinic Foundation, F25, 9500 Euclid Avenue, Cleveland, OH 44195. Telephone: 216-444-2755. Fax: 216-444-3407
  • ,
  • Oussama Wazni, MD

      Affiliations

    • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
  • ,
  • Fuad Jubran, MD

      Affiliations

    • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
  • ,
  • Nicholas Smedira, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Cleveland Clinic Foundation, Kaufman Center for Heart Failure, Cleveland, Ohio

Received 26 July 2005 ,Revised 27 July 2005 ,Accepted 11 October 2005.

References 

  1. Goldberg RJ , Gore JM , Alpert JS , et al.   Cardiogenic shock after acute myocardial infarction (incidence and mortality from a community-wide perspective, 1975 to 1988) . N Engl J Med . 1991;325:117–122
  2. Hochman JS , Sleeper LA , Webb JG , et al.   Early revascularization in acute myocardial infarction complicated by cardiogenic shock . N Engl J Med . 1999;341:625–634
  3. Hochman JS , Sleeper LA , White HD , et al.   One-year survival following early revascularization for cardiogenic shock . JAMA . 2001;285:190–192
  4. Hollenberg SM , Kavinsky CJ , Parillo JE . Cardiogenic shock . Ann Intern Med . 1999;131:47–59
  5. Wilcox RG , von der Lippe G , Olsson CG , et al.   Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET) . Lancet . 1988;2:525–530
  6. Second International Study of Infarct Survival (ISIS-2) Collaborative Group . Randomized trial of intravenous streptokinase, oral aspirin both, or neither among 17,187 cases of suspected acute myocardial infarction (ISIS-2) . Lancet . 1988;2:349–360
  7. The GUSTO Investigators . An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction . N Engl J Med . 1993;329:673–682
  8. Holmes DR , Bates ER , Kleiman NS , et al.   Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-1 Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries . JAMA . 1995;26:668–674
  9. AIMS Trial Study Group . Effect of intravenous APSAC on mortality after acute myocardial infarction (preliminary report of a placebo controlled clinical trial) . Lancet . 1988;1:545–549
  10. The GUSTO Angiographic Investigators . The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction . N Engl J Med . 1993;329:1615–1622
  11. Grines CL , Browne KF , Marco J , et al.  The Primary Angioplasty in Myocardial Infarction Study Group   A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction . N Engl J Med . 1993;328:673–679
  12. Gibbons RJ , Holmes DR , Reeder GS , et al.  The Mayo Coronary Care Unit and Catheterization Laboratory Groups   Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment of myocardial infarction . N Engl J Med . 1993;328:685–691
  13. TIMI Study Group . The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase 1 findings . N Engl J Med . 1985;312:932–936
  14. Antman EM , Anbe DT , Armstrong PW , et al.   ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) . Circulation . 2004;110:588–636
  15. Babaev A , Frederick PD , Pasta D , et al.   Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock . JAMA . 2005;294:448–454
  16. Hosenpud JD , Bennett LE , Keck BM , et al.   The registry of the International Society for Heart and Lung Transplantation (sixteenth official report—1999) . J Heart Lung Transplant . 1999;18:611–626
  17. Rose EA , Gelijns AC , Moskowitz AJ , et al.   Long-term mechanical left ventricular assistance for end-stage heart failure . N Engl J Med . 2001;345:1435–1443
  18. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult—summary article . J Am Coll Cardiol . 2005;46:1116–1143
  19. Kherani AR , Maybaum S , Oz MC . Ventricular assist devices as a bridge to transplant or recovery . Cardiology . 2004;101:93–103
  20. Col N , Gurwitz J , Alpert J , Goldberg R . Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy . Am J Cardiol . 1994;73:149–157
  21. Dioguardi N , Lotto A , Levi G , et al.   Controlled trial of streptokinase and heparin in acute myocardial infarction . Lancet . 1971;2:891–895
  22. Mathey D , Kuck KH , Tilsner V , et al.   Nonsurgical coronary artery recanalization in acute transmural myocardial infarction . Circulation . 1982;63:489–497
  23. Kennedy JW , Gensini GG , Timmis GC , Maynard C . Acute myocardial infarction treated with intracoronary streptokinase (a report of the Society for Cardiac Angiography) . Am J Cardiol . 1985;55:871–877
  24. Fibrinolytic Therapy Trialists (FTT) Collaborative Group . Indications for fibrinolytic therapy in suspected acute myocardial infarction (collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients) . Lancet . 1994;343:311–322
  25. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI) . Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction . Lancet . 1986;1:397–401
  26. Menon V , Hochman JS , Stebbins A , et al.   Lack of progress in cardiogenic shock (lessons from the GUSTO trials) . [see comment] [Multicenter Study] European Heart Journal . 2000;21:1928–1936
  27. Shawl FA , Domanski MJ , Hernandez TJ , Punja S . Emergency percutaneous cardiopulmonary bypass support in cardiogenic shock from acute myocardial infarction . Am J Cardiol . 1989;64:967–970
  28. O’Neill WW , Embel R , Laufer N , et al.   Coronary angioplasty therapy of cardiogenic shock complicating acute myocardial infarction . Circulation . 1985;72(suppl III):III-309
  29. O’Keefe JH , Bailey WL , Rutherford BD , Hartzler GO . Primary angioplasty for acute myocardial infarction in 1,000 consecutive patients. Results in an unselected population and high-risk subgroups . Am J Cardiol . 1993;72:107G–115G
  30. Califf RM , Bengtson JR . Cardiogenic shock . N Engl J Med . 1994;330:1724–1730
  31. Bengtson JR , Kaplan AJ , Pieper KS , et al.   Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era . JAMA . 1992;20:1482–1489
  32. Grines CL , Browne KF , Marco J , et al.  The Primary Angioplasty in Myocardial Infarction Study Group   A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction . N Engl J Med . 1993;328:673–679
  33. Gacioch GM , Ellis SG , Lee L , et al.   Cardiogenic shock complicating acute myocardial infarction (the use of coronary angioplasty and the integration of the new support devices into patient management) . JAMA . 1992;19:647–653
  34. De Wood MA , Notske RN , Hensley GR , et al.   Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock . Circulation . 1980;61:1105–1112
  35. Kirklin JK , Blackstone EH , Zorn GL , et al.   Intermediate-term results of coronary artery bypass grafting for acute myocardial infarction . Circulation . 1985;72(suppl II):II-175–II-178
  36. Phillips SJ , Kongtahworn C , Skinner JR , Zeff RH . Emergency coronary artery reperfusion. A choice therapy for evolving myocardial infarction: results in 339 patients . J Thorac Cardiovasc Surg . 1983;86:679–688
  37. Laks H , Rosenkranz E , Buckberg GD . Surgical treatment of cardiogenic shock after myocardial infarction . Circulation . 1986;74(suppl III):III-11–III-16
  38. Frazier OH , Rose EA , McCarthy P , et al.   Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system . Ann Surg . 1995;222:327–338
  39. McCarthy PM , Smedira NG , Vargo RL , et al.   One-hundred patients with the HeartMate left ventricular assist device (evolving concepts and technology) . J Thorac Cardiovasc Surg . 1998;115:904–912
  40. Frazier OH , Macris MP , Myers TJ , et al.   Improved survival after extended bridge to cardiac transplantation . Ann Thorac Surg . 1994;57:1416–1422
  41. Oz MC , Rose EA , Levin HR . Selection criteria for placement of left ventricular assist devices . Am Heart J . 1995;129:173–177
  42. Oz MC , Goldstein DJ , Pepino P , et al.   Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices . Circulation . 1995;92(suppl II):II-169–II-173
  43. Park SJ , Nguyen DQ , Bank AH , et al.   Left ventricular assist device bridge therapy for acute myocardial infarction . Ann Thorac Surg . 2000;69:1146–1151
  44. Chen JM , DeRose JJ , Slater JP , et al.   Improved survival rates support left ventricular assist device implantation early after myocardial infarction . J Am Coll Cardiol . 1999;33:1903–1908
  45. Hendry PJ , Masters RG , Mussivand TV , et al.   Circulatory support for cardiogenic shock due to acute myocardial infarction (a Canadian experience) . Can J Cardiol . 1999;15:1090–1094
  46. Anderson H , Steimle C , Shapiro M , et al.   Extracorporeal life support for adult cardiorespiratory failure . Surgery . 1993;114:161–173
  47. Smedira NG , Blackstone EH . Postcardiotomy mechanical support (risk factors and outcomes) . Ann Thorac Surg . 2001;71(suppl 3):S60–S66
  48. Pagani FD , Lynch W , Swaniker F , et al.   Extracorporeal life support to left ventricular assist device bridge to heart transplant (a strategy to optimize survival and resource utilization) . Circulation . 1999;100(suppl 19):II-206–II-210

PII: S1053-2498(06)00007-6

doi: 10.1016/j.healun.2005.10.011

The Journal of Heart and Lung Transplantation
Volume 25, Issue 5 , Pages 504-509 , May 2006